Sage Journals: Discover world-class research

Free access

Research article

First published 2018-4

Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

Martine De Vos, Barbara Dhooghe, Severine Vermeire [...]

United European Gastroenterology Journal

Free access

Research article

First published 2020-11

Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational,multicenter,retrospective cohort study

Nathaniel Aviv Cohen, Nikolas Plevris, Uri Kopylov [...]

United European Gastroenterology Journal

Open access

Research article

First published 2026

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry

Ondrej Hradsky, Dana Duricova, Milan Lukas [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Risk factors and clinical characteristics of Clostridium difficile colonization and infection in patients with inflammatory bowel disease exposed to Vedolizumab: a multicenter retrospective study

Qing Li, Xiaomei Song, Peizhu Su [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2018-2

Reporting on Adverse Clinical Events

Clin-Alert

Open access

Research article

First published 2024

Short-term effectiveness and safety of ustekinumab and vedolizumab in elderly and non-elderly patients with Crohn’s disease: a comparative study

Lior Dar, Uria Shani, Arad Dotan [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2017-8

Compliance with the faecal calprotectin test in patients with inflammatory bowel disease

Chloé Maréchal, Isabelle Aimone-Gastin, Cédric Baumann [...]

United European Gastroenterology Journal

Open access

Research article

First published 2021

Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis

Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2020

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease

Renske W. M. Pauwels, Christien J. van der Woude, Nicole S. Erler [...]

Therapeutic Advances in Gastroenterology

Search results